Mandate
Nonpartisan civic intelligence

Congress, translated. Representatives, measured. Both sides, side by side.

Mandate reads every bill on the House and Senate floor and explains it in plain English — with equal-weight arguments from supporters and opponents.

Non partisanPrimary-source cited500+ bills, 119th Congress
What it looks like

Built for people who actually want to know what their government is doing.

9:41
Feed
For You
Trending
Your Reps
12 new bills
Healthcare
On Floor
Caps insulin at $35/month for all insured Americans
Extends the current Medicare insulin cap to private insurance plans, affecting ~7 million Americans.
Impact8 / 10
HR 1024·Sep 12, 2025·Your rep: YES
TechnologyUnder Radar
In Committee
Restricts data brokers from selling location data
Impact6 / 10
S 472·Sep 10, 2025
Feed
Search
Floor
01The feed
9:41
HR 1024
Insulin Price Cap Act
On Floor
Healthcare
Caps insulin at $35/month for all insured Americans
Extends the Medicare insulin cap to private insurance plans, affecting ~7M Americans.
Ask Mandate about this bill
The debate
Supporters say
Caps OOP costs for 7M patients. Ends rationing.
Opponents say
Price controls reduce R&D by 0.8% long-term.
House roll callSep 11, 2025
Yea 287Nay 143NV 5
Feed
Search
Floor
02Both sides, equal weight
9:41
HR 1024
Insulin Price Cap Act
Ask Mandate
About HR 1024
Who does this actually help and who pays?
Based on the CBO score and committee markup: ~7M Americans with diabetes would see out-of-pocket costs drop by an estimated $4,200/yr. Opponents cite a projected 0.8% reduction in industry R&D reinvestment over 10 years.
CBO · Insulin Price Cap Act, 2024
HR 1024 · Sec. 3(a) — Private plan cap
Ways & Means markup · Aug 2025
Ask about this bill…
03Cited answers
What it looks like · Live now— pulled from the floor this session
Live
HR 1024287–143CBO/59-2024+$23B / 10yS 910advancingArt. I §8indexedHR 88committeeMandate score+2.1 avgSCOTUS docket70+ casesKFF brief09/25W&M markup08/25HR 2055stalledDobbscross-refMembers tracked535Am. XIV §1citedAudit pass rate96%HR 1024287–143CBO/59-2024+$23B / 10yS 910advancingArt. I §8indexedHR 88committeeMandate score+2.1 avgSCOTUS docket70+ casesKFF brief09/25W&M markup08/25HR 2055stalledDobbscross-refMembers tracked535Am. XIV §1citedAudit pass rate96%
What Mandate does

One question in. One cited answer out.

Mandate reads every bill, vote, and filing — then answers your question in plain English, with every claim traceable to primary source.

Ask any question about Congress. Get a cited answer in seconds.

No opinion. No spin. Every sentence traces back to a bill, a vote, a filing, or a CBO score — pulled live, rendered in plain English.

Try a question belowWatch it resolveInspect every source
1
Parse query
122 ms
2
Pull primary sources
H.Roll 412CBO/59-2024KFF 09/25W&M markup
3
Cross-check · 2 models
2.3 s·agreement

H.R. 1024 passed the House on September 11, 2025, by a margin of 287–143 (5 not voting)¹. The bill caps out-of-pocket insulin at $35 per month for privately-insured patients.

The CBO scored the 10-year impact at +$23B to the deficit, with an average savings of $4,200 per patient annually². Supporters argue it extends the 2022 Medicare Part D cap³; opponents note that analogous price controls may reduce manufacturer R&D investment.

CaveatMandate does not model downstream R&D effects. Analysis is drawn solely from the cited sources; read the full CBO brief for methodology.

Primary sources
  1. Roll CallH.Roll 412 · 9/11/25
  2. CBOCost Estimate 59-2024 · 8/28/25
  3. Text§3(a), 21 U.S.C. § 1395w-114(d)(2)
  4. CommitteeW&M markup · 8/14/25
The rules we ship by

Four rules. Each one enforced by the product, not the policy.

Most neutrality promises live in a press release. Ours live in the component library — so they hold up under every commit.

PRINCIPLE · 01

Equal weight, equal length.

Every pro argument ships next to an opposing argument of equal prominence. Neither side gets the last word. The UI is literally split 50/50 — and the layout engine snaps it back when someone tries to tip it.

Enforced in DebateSplit.tsx
Live componentDebateSplit
For · 50%Against · 50%
Supporter case
Caps insulin at $35/mo for private plans. CBO: $4.2k avg savings.
Opponent case
Imposes price controls that may reduce manufacturer R&D incentive.
Balanced · 50/50
PRINCIPLE · 02
Editorial copy · after auditLive
HR 1024 is a controversial bill that far-reaching consequences and is very expensive.
Adjective
Replaced with data
H.Roll 412KFF coverage briefCBO/59-2024

Data, not adjectives.

We count votes. We cite the CBO. We link the committee markup. We never tell you a bill is "controversial" or "far-reaching" — we tell you who it affects and by how much.

Auditor dimension editorializing ≥ 0.90
PRINCIPLE · 03

Party colors stay small.

Blue and red appear only as 8px dots next to names. Never as tinted backgrounds, never as card fills. The color of a representative is not a headline.

Token party-dot.size = 8px · capped
Member rowParty indicator
Sen. Maria Cantwell
D · WA
Sen. John Thune
R · SD
Rep. Ro Khanna
D · CA-17
Try to scale8px
 
PRINCIPLE · 04
Answer structureIRAC · minus Conclusion
01
Issue
What does this bill actually do, and to whom?
02
Provision
The specific sections and language that carry the change.
03
Supporter case
The strongest argument for, quoted or fairly summarized.
04
Opponent case
The strongest argument against, quoted or fairly summarized.
05
Context
Precedent, prior votes, CBO scoring, historical pattern.
06
The conclusion — is yours.
Deliberate refusal · not a missing step

We stop where you start.

Every answer presents the issue, the provision, the supporter case at full strength, the opponent case at full strength, and the historical context. Then it hands the decision to you. You get the information required to form a view — the bill text, who benefits, who's affected, the precedent, the vote record. You don't get a nudge toward a side. Citizenship isn't delegated to an algorithm. Mandate informs. You decide.

IRAC minus Conclusion · reader-owned reasoning
500+
Bills analyzed · 119th Congress
535
Members tracked
$0
From political donors
50/50
Pro / con split, always
© 2026 Mandate, Inc.Source ratings via AllSides · Media Bias/Fact Check